Kiniksa Pharmaceuticals International, plc (KNSA)

SEC filing

Kiniksa Pharmaceuticals International, plc

KNSA · CIK 1730430

4 · May 1, 2026 · Patel Sanj K sold 48.56K shares at $54.02/share ($2.6M); exercised options for 48.56K shares

Patel Sanj K sold 48.56K shares at $54.02/share ($2.6M); exercised options for 48.56K shares

xslF345X06/form4-05012026_080517.xml

xslF345X06/form4-05012026_080517.xmlSEC.gov

Graphics and non-inline formats (not embedded below).